Lingvay I, Hansen T, Macura S, Marre M, Nauck MA, de la Rosa R, et al
This study highlights how NAD+ levels decline in both mouse and human Alzheimers brain samples and how boosting NAD+ may prevent and reverse neurodegeneration and cognitive decline
As the body ages, natural levels of GHK-Cu decline, which contributes to thinning skin, loss of elasticity, slower regeneration, dullness, and more visible signs of aging
In comparison to subcutaneous injection, for oral administration, we consider a positive signal when the odds ratio (OR) is greater than 1 and the confidence interval does not include 1
Weight Loss: In phase III trials, weight loss with the use of exenatide averaged between 0.9 and 2.8 kg over a 30-month time frame, with more weight loss associated when exenatide is added to existing metformin therapy